Supplementary Appendix - Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak

Name: Supplementary Appendix - Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak
Creator: Jesse Veenstra
Published: 2020-08-24T15:44:21.355Z
Keywords: Dermatology, Immunosuppressive Therapy, Immune-Mediated Illness, COVID-19

Veenstra, Jesse

doi:10.17632/hwf6mwdccj.2

Supplementary Appendix - Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak

Published: 24-08-2020| Version 2 | DOI: 10.17632/hwf6mwdccj.2

Contributor:

Jesse Veenstra

Description

Supplemental figures and tables

Supplementary Appendix - Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak

Description

Files